Thursday , October 19 2017
Home / Resources / Exclusive Interviews / The Beta-Cell is Final Common Denominator of Beta-Cell Damage

The Beta-Cell is Final Common Denominator of Beta-Cell Damage

stanley_schwartzIn part five of this special interview with DIC publisher Steve Freed, Dr. Stanley Schwartz discusses in-depth the mechanisms by which beta cell damage contributes to hyperglycemia and the targeted treatments for mediating pathways of hyperglycemia.

Fill out my online form.
Use Wufoo integrations and get your data to your favorite apps.

View the complete video series of this special interview with Dr. Schwartz:

Part 1: Defining the Classifications of the New System

Part 2: Beta-Cell Construct: Egregious Eleven

Part 3: Targeted Treatments for Mediating Pathways of Hyperglycemia

Part 4: Individualization of Patient Care

Part 5: The Beta-Cell is Final Common Denominator of Beta-Cell Damage

Part 6: New Classification for Monogenic and Pre-Diabetes

Part 7: Supporters of New Classification of Diabetes

You can find all of Dr. Schwartz’s Diabetes In Control articles and videos as well as his biography here.